Impact of Lifestyle Interventions on Gynecologic Cancers: Beyond Diet and Exercise.
Nathalie D McKenzie, Sarfraz Ahmad
https://pubmed.ncbi.nlm.nih.gov/39184272Actively Recruiting
Phase Not Applicable
Age: 18Years +
FEMALE
ID07121738
A Prospective Study of a Lifestyle Medicine Survivorship Program for Patients With Gynecologic Cancer
Led by AdventHealth · Updated on 2026-03-03
64
Participants Needed
1
Research Sites
N/A
Total Duration
On this page
Sponsors
A
AdventHealth
Lead Sponsor
S
State of Florida Department of Health
Collaborating Sponsor
AI-Summary
What this Trial Is About
Researchers are evaluating the effects of an 8-week Healthy Eating Active Lifestyle (HEAL)-GYN program designed for patients with gynecologic cancer. This telemedicine-based rehabilitation focuses on lifestyle changes including exercise, nutrition, sleep, social integration, stress management, and avoiding risk behaviors like smoking and alcohol. The study aims to assess impacts on participants' confidence in managing their health, lifestyle habits, mental health, overall well-being, and biological markers. The HEAL-GYN program is led by a certified lifestyle medicine oncologist and involves personalized goal-setting and practical instruction on healthy living. Up to 64 participants will engage in this behavioral intervention conducted remotely. The program includes regular monitoring through surveys and wearable activity trackers to measure physical activity and sleep. Participants will complete surveys at the start, end of the 8-week program, and at 1-month and 3-month follow-ups. These surveys use validated tools to assess lifestyle factors, mental health, and quality of life. Home health visits will collect biometric data and blood samples to analyze lab values and biomarkers such as adiponectin, insulin sensitivity, and inflammatory markers. This comprehensive monitoring supports evaluation of the program’s effects over time.
CONDITIONS
Brief Title
A Prospective Study of a Lifestyle Medicine Survivorship Program for Patients With Gynecologic Cancer
Who Can Participate
Age: 18Years +
FEMALE
Eligibility Criteria
You may qualify if you...
- Adult 18 years old or over
- Diagnosis of gynecologic cancer
- Current patient in the Central Florida area
- Completing or have completed chemotherapy treatment within approximately the past 3 months before starting the program
- Able to speak, read, and understand the English language.
You will not qualify if you...
- Not willing or able to provide informed consent
- Not willing or able to comply with all study procedures and requirement for the duration of the study
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
1
2
3
Your Study Journey
Screening
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person or remote) for eligibility assessment
Outpatient Treatment
Duration - 8 weeks
Participants undergo an 8-week telemedicine-based lifestyle medicine program focusing on exercise, nutrition, sleep, social integration, stress management, and avoidance of risk behaviors with personalized goal-setting and instruction.
Weekly remote visits for up to 8 weeks
Follow-up
Duration - 3 months
Participants complete follow-up assessments including surveys and biometric measurements to evaluate lifestyle factors, mental health, and biomarkers at 1 month and 3 months after the intervention ends.
3 visits including 1-month and 3-month follow-up assessments
Trial Site Locations
Total: 1 location
1
AdventHealth
Orlando, Florida, United States, 32803
Actively Recruiting
Loading map...
Research Team
A
Amanda T Sawyer, PhD
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
SUPPORTIVE_CARE
Number of Arms
1
Similar Trials
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Published Research Related To This Trial
Self-efficacy in weight management.
M M Clark, D B Abrams, R S Niaura...
https://pubmed.ncbi.nlm.nih.gov/1955608Cognitive research enhances accuracy of food frequency questionnaire reports: results of an experimental validation study.
Frances E Thompson, Amy F Subar, Charles C Brown...
https://pubmed.ncbi.nlm.nih.gov/11846115The Pittsburgh Sleep Quality Index: a new instrument for psychiatric practice and research.
D J Buysse, C F Reynolds, T H Monk...
https://pubmed.ncbi.nlm.nih.gov/2748771The assessment of body image in cancer patients.
P Hopwood
https://pubmed.ncbi.nlm.nih.gov/8422297A global measure of perceived stress.
S Cohen, T Kamarck, R Mermelstein
https://pubmed.ncbi.nlm.nih.gov/6668417A brief measure for assessing generalized anxiety disorder: the GAD-7.
Robert L Spitzer, Kurt Kroenke, Janet B W Williams...
https://pubmed.ncbi.nlm.nih.gov/16717171The PHQ-9: validity of a brief depression severity measure.
K Kroenke, R L Spitzer, J B Williams
https://pubmed.ncbi.nlm.nih.gov/11556941The Functional Assessment of Chronic Illness Therapy (FACIT) Measurement System: properties, applications, and interpretation.
Kimberly Webster, David Cella, Kathleen Yost
https://pubmed.ncbi.nlm.nih.gov/14678568Reliability across studies from the functional assessment of cancer therapy-general (FACT-G) and its subscales: a reliability generalization.
David Victorson, Joshua Barocas, Juliette Song...
https://pubmed.ncbi.nlm.nih.gov/18841493